References
- Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. IJMS. 2019;20(21):5376. doi:https://doi.org/10.3390/ijms20215376.
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315(8):801–10. doi:https://doi.org/10.1001/jama.2016.0287.
- Reilly JP, Meyer NJ, Christie JD. Genetics in the prevention and treatment of sepsis. Cham: Humana Press; 2017. p. 237–64. doi:https://doi.org/10.1007/978-3-319-48470-9_15.
- Ferdosian F, Jarahzadeh MH, Bahrami R, Nafei Z, Jafari M, Raee-Ezzabadi A, et al. Association of IL-6 -174G > C polymorphism with susceptibility to childhood sepsis: A systematic review and meta-analysis. Fetal Pediatr Pathol. 2020;1–15. doi:https://doi.org/10.1080/15513815.2020.1723149. [Epub ahead of print].
- Zekavat OR, Makarem A, Bahrami R, Dastgheib N, Dehghani SJ. Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality. Pediatric Health Med Ther. 2019;10:33–7. doi:https://doi.org/10.2147/PHMT.S202080. eCollection 2019.
- Hsu HE, Abanyie F, Agus MSD, Balamuth F, Brady PW, Brilli RJ, Carcillo JA, Dantes R, Epstein L, Fiore AE, et al. A national approach to pediatric sepsis surveillance. Pediatrics. 2019;144(6):e20191790. doi:https://doi.org/10.1542/peds.2019-1790.
- Rhee C, Klompas M. Sepsis trends: Increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis. 2020;12(Suppl 1):S89–S100. doi:https://doi.org/10.21037/jtd.2019.12.51.
- Patel K, McElvania E. Diagnostic challenges and laboratory considerations for pediatric sepsis. J Appl Lab Med. 2019;3(4):587–600. doi:https://doi.org/10.1373/jalm.2017.025908.
- Mathias B, Mira JC, Larson SD. Pediatric sepsis. Curr Opin Pediatr. 2016;28(3):380–7. doi:https://doi.org/10.1097/MOP.0000000000000337.
- Kawasaki T. Update on pediatric sepsis: A review. J Intensive Care. 2017;5:47. doi:https://doi.org/10.1186/s40560-017-0240-1.
- Eslami Z, Lookzadeh MH, Noorishadkam M, Hashemi A, Ghilian R, Pirdehghan A. Thrombocytopenia and associated factors in neonates admitted to NICU during years 2010–2011. Iran J Ped Hematol Oncol. 2013;3(1):205–15.
- Lu X, Xue L, Sun W, Ye J, Zhu Z, Mei H. Identification of key pathogenic genes of sepsis based on the gene expression omnibus database. Mol Med Rep. 2018;17(2):3042–54. doi:https://doi.org/10.3892/mmr.2017.8258.
- Van Der Poll T, Van De Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407–20. doi:https://doi.org/10.1038/nri.2017.36.
- Villar J, Maca-Meyer N, Pérez-Méndez L, Flores C. Bench-to-bedside review: Understanding genetic predisposition to sepsis. Crit Care. 2004;8(3):180–9. doi:https://doi.org/10.1186/cc2863.
- Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437(7061):1032–7. doi:https://doi.org/10.1038/nature03985.
- Gohari M, Dastgheib SA, Noorishadkam M, Lookzadeh MH, Mirjalili SR, Akbarian-Bafghi MJ, Morovati-Sharifabad M, Neamatzadeh H. Association of eNOS and ACE Polymorphisms with retinopathy of prematurity: A systematic review and meta-analysis. Fetal Pediatr Pathol. 2019;1–12. doi:https://doi.org/10.1080/15513815.2019.1652378. [Epub ahead of print].
- Aslbahar F, Neamatzadeh H, Tabatabaiee RS, Karimi-Zarchi M, Javaheri A, Mazaheri M, Foroughi E, Nasiri R. Association of angiotensin-converting enzyme insertion/deletion polymorphism with recurrent pregnancy loss: a meta-analysis of 26 case-control studies. Rev Bras Ginecol Obstet. 2018;40(10):631–41. doi:https://doi.org/10.1055/s-0038-1672137.
- Fallah M, Shen Y, Brodén J, Bäckman A, Lundskog B, Johansson M, Blomquist M, Liu K, Wilczynska M, Ny T, et al. Plasminogen activation is required for the development of radiation-induced dermatitis. Cell Death Dis. 2018;9(11):1051. doi:https://doi.org/10.1038/s41419-018-1106-8.
- Moghimi M, Kargar S, Jafari MA, Ahrar H, Jarahzadeh MH, Neamatzadeh H, Sadeghizadeh- Yazdi J. Angiotensin converting enzyme insertion/deletion polymorphism is associated with breast cancer risk: A meta-analysis. Asian Pac J Cancer Prev. 2018;19(11):3225–31. doi:https://doi.org/10.31557/APJCP.2018.19.11.3225.
- Lee NR, Hwang IW, Kim HJ, Kang YD, Park JW, Jin HJ. Genetic association of angiotensin-converting enzyme (ACE) gene I/D polymorphism with preterm birth in Korean women: Case-control study and meta-analysis. Medicina (Kaunas). 2019;55(6):264. doi:https://doi.org/10.3390/medicina55060264.
- Soleimani-Jadidi S, Abbasi H, Javaheri A, Behforouz A, Zanbagh L, Meibodi B, et al. Cumulative evidence for association of IL-10 -1082G > A polymorphism with susceptibility to recurrent pregnancy loss: A systematic review and meta-analysis. Fetal Pediatr Pathol. 2020;1–15. doi:https://doi.org/10.1080/15513815.2020.1716903. [Epub ahead of print].
- Abbasi H, Dastgheib SA, Hadadan A, Karimi-Zarchi M, Javaheri A, Meibodi B, et al. Association of endothelial nitric oxide synthase 894G > T polymorphism with preeclampsia risk: A systematic review and meta-analysis based on 35 studies. Fetal Pediatr Pathol. 2020;1–16. doi:https://doi.org/10.1080/15513815.2019.1710880. [Epub ahead of print].
- Salimi E, Karimi-Zarchi M, Dastgheib SA, Abbasi H, Tabatabaiee RS, Hadadan A, Amjadi N, Akbarian-Bafghi MJ, Neamatzadeh H. Association of promoter region polymorphisms of IL-6 and IL-18 genes with risk of recurrent pregnancy loss: A systematic review and meta-analysis. Fetal Pediatr Pathol. 2019;1–14. doi:https://doi.org/10.1080/15513815.2019.1652379. [Epub ahead of print].
- Armangil D, Yurdakök M, Okur H, Gürgey A. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome. Clin Appl Thromb Hemost. 2011;17(4):352–7. doi:https://doi.org/10.1177/1076029610369796.
- Wei Y, Zeng Q, Z H. 4G/5G promoter polymorphism in the plasminogen activator inhibitor 1 gene in children with sepsis. Chin J Evid Based Pediatr. 2008;3:280–5. doi:https://doi.org/10.1111/j.1538-7836.2007.02724.x.
- Spiegler J, Gilhaus A, Konig IR, Kattner E, Vochem M, Kuster H, Moller J, Muller D, Kribs A, Segerer H, et al. Polymorphisms in the renin-angiotensin system and outcome of very-low-birthweight infants. Neonatology. 2010;97(1):10–4. doi:https://doi.org/10.1159/000226602.
- Çelik Ü, Yildizdaş D, Çelik T, Alhan E, Atila G, Tepe T, Sertdemir Y. Relationship between angiotensin-converting enzyme gene polymorphism (insertion/deletion) and the clinical condition of sepsis in Turkish children. Turkiye Klinikleri J Med Sci. 2010;30(2):591–7. doi:https://doi.org/10.5336/medsci.2008-8223.
- Sobhan MR, Mahdinezhad-Yazdi M, Dastgheib SA, Jafari M, Raee-Ezzabadi A, Neamatzadeh H. Association of ESRα XbaI A > G, ESRα PvuII T > C and ESRβ AlwNI T > C polymorphisms with the risk of developing adolescent idiopathic scoliosis: A systematic review and genetic meta-analysis. Rev Bras Ortop (Sao Paulo). 2020;55(1):8–16. doi:https://doi.org/10.1016/j.rboe.2018.03.001.
- Gohari M, Dastgheib AS, Jafari-Nedooshan J, Akbarian-Bafghi JM, Morovati-Sharifabad M, Mirjalili RS, Neamatzadeh H. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G polymorphisms with risk of retinoblastoma. Klin Onkol. 2019;32(5):375–9. doi:https://doi.org/10.14735/amko2019375.
- Sadeghiyeh T, Dastgheib SA, Mirzaee-Khoramabadi K, Morovati-Sharifabad M, Akbarian-Bafghi MJ, Poursharif Z, Mirjalili SR, Neamatzadeh H. Association of MTHFR 677C > T and 1298A > C polymorphisms with susceptibility to autism: A systematic review and meta-analysis. Asian J Psychiatr. 2019;46:54–61. doi:https://doi.org/10.1016/j.ajp.2019.09.016.
- Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet. 1999;354(9178):556–60. doi:https://doi.org/10.1016/S0140-6736(99)02220-5.
- Haralambous E, Hibberd ML, Hermans PWM, Ninis N, Nadel S, Levin M. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med. 2003;31(12):2788–93. doi:https://doi.org/10.1097/01.CCM.0000100122.57249.5D.
- Geishofer G, Central European Meningococcal Genetic Study Group, Binder A, Müller M, Zöhrer B, Resch B, Müller W, Faber J, Finn A, Endler G, Mannhalter C, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr. 2005;164(8):486–90. doi:https://doi.org/10.1007/s00431-005-1673-4.
- Bunker-Wiersma HE, Koopmans RP, Kuipers TW, Knoester H, Bos AP. Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection. Pediatr Crit Care Med. 2008;9(5):517–23. doi:https://doi.org/10.1097/PCC.0b013e318184985b.
- Cogulu O, Onay H, Uzunkaya D, Gunduz C, Pehlivan S, Vardar F, Atlihan F, Ozkinay C, Ozkinay F. Role of angiotensin-converting enzyme gene polymorphisms in children with sepsis and septic shock. Pediatr Int. 2008;50(4):477–80. doi:https://doi.org/10.1111/j.1442-200X.2008.02583.x.
- Shi C, Sui Z, Li L, Yang R. No association of SERPINE1 -675 polymorphism with sepsis susceptibility: A meta-analysis. Medicine (Baltimore). 2015;94(45):e1173. doi:https://doi.org/10.1097/MD.0000000000001173.
- Shi Q, Mu X, Hong L, Zheng S. SERPINE1 rs1799768 polymorphism contributes to sepsis risk and mortality. J Renin Angiotensin Aldosterone Syst. 2015;16(4):1218–24. doi:https://doi.org/10.1177/1470320315614714.
- Li L, Nie W, Zhou H, Yuan W, Li W, Huang W. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: A meta-analysis. PLoS One. 2013;8(1):e54883. doi:https://doi.org/10.1371/journal.pone.0054883.
- Hou X, Zhang P, Nie W, Tang S, Wang J, Zhang Q, Wan Z, Zhang B, Song B. Association between angiotensin-converting enzyme I/D polymorphism and sepsis: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2015;16(2):415–21. doi:https://doi.org/10.1177/1470320313492361.
- Kovaleva E, Pokhylko V, Chernyavskaya Y, Kalyuzka E, Poltoropavlov V. Analysis of the associations between angiotensin-converting enzyme gene polymorphism and arterial hypotension in premature infants with early onset bacterial infections. Georgian Med News. 2015;248:60–8. [Article in Russian]
- Baier RJ, Loggins J, Yanamandra K. Angiotensin converting enzyme insertion/deletion polymorphism does not alter sepsis outcome in ventilated very low birth weight infants. J Perinatol. 2005;25(3):205–9. doi:https://doi.org/10.1038/sj.jp.7211231.